Comment on

• Influence of blood pressure on the effects of low-dose asprin in elderly patients with multiple atherosclerotic risks.

  Ando K, Shimada K, Yamazaki T, Uchiyama S, Uemura Y, Ishizuka N, Teramoto T, Oikawa S, Sugawara M, Murata M, Yokoyama K, Ikeda Y; Japanese Primary Prevention Project (JPPP) Study Group. Ando K, et al. J Hypertens. 2019 Jun;37(6):1301-1307. doi: 10.1097/HJH.0000000000002034. J Hypertens. 2019. PMID: 31022110
• Aspirin in primary prevention: 'nothing else matters' … like hypertension.

  Volpe M, Gallo G. Volpe M, et al. J Hypertens. 2019 Nov;37(11):2298-2299. doi: 10.1097/HJH.0000000000002205. J Hypertens. 2019. PMID: 31567756 No abstract available.